玻尿酸填充劑最大的安全優勢在於可用玻尿酸酶(hyaluronidase)溶解。如果填充效果不理想、出現不對稱,或發生血管阻塞等緊急狀況,醫師可以立即注射玻尿酸酶來溶解填充物。這是其他永久性填充劑(如矽膠、PMMA)所沒有的安全保障。研究顯示玻尿酸酶用於 HA 相關血管阻塞的成功率高達 84.2%(PMID: 40406769)。
1. Bianchini S, et al. "Adverse Events Associated with Hyaluronic Acid Filler Injection for Non-surgical Facial Aesthetics: A Systematic Review of High Level of Evidence Studies." Aesthetic Plast Surg. 2023;47(5):1998-2013. PMID: 37563436 — 高證據等級系統性回顧,確認 HA 填充劑常見不良事件發生率
2. Miao Y, et al. "Risk Factor Analysis for Vascular Occlusions After Dermal Filler Injections: A Systematic Review and Meta-Analysis." Aesthetic Plast Surg. 2025. PMID: 40406769 — 血管阻塞風險因子分析,玻尿酸酶治療成功率 84.2%
3. Bianchini S, et al. "Monophasic and Biphasic Hyaluronic Acid Fillers for Esthetic Correction of Nasolabial Folds: A Meta-Analysis of Randomized Controlled Trials." Aesthetic Plast Surg. 2022;46(2):1015-1024. PMID: 35066619 — 22 項 RCT、1,848 位受試者統合分析
4. Alam M, et al. "Hyaluronic Acid Filler Longevity in the Mid-face: A Review of 33 Magnetic Resonance Imaging Studies." Dermatol Surg. 2024;50(8):719-724. PMID: 39015357 — MRI 追蹤顯示 HA 填充劑在中臉可存留 2-15 年
5. Chen Y, et al. "Serious Complications of Hyaluronic Acid Fillers — A Retrospective Study of 290,307 Cases." Aesthet Surg J. 2025. PMID: 40358958 — 大規模回顧性研究,確認血管阻塞為最嚴重 HA 併發症
6. Lin MJ, et al. "Safety and efficacy of hyaluronic acid injectable filler in the treatment of nasolabial fold wrinkle: a randomized, double-blind, self-controlled clinical trial." J Cosmet Dermatol. 2023;22(12):3355-3362. PMID: 37694979 — 隨機雙盲自身對照試驗